Results: 4

Recent advances in the epidemiology, diagnosis and treatment of endomyocardial fibrosis in Africa

Heart; 99 (20), 2013
Endomyocardial fibrosis (EMF) continues to be an important and disabling disease in many parts of Africa, although its prevalence has declined in some parts of the continent. Increased access to medical care in general and increased availability of echocardiography in some parts of the continent have led...

Recent advances in the epidemiology, diagnosis and treatment of endomyocardial fibrosis in Africa

Heart; 99 (20), 2012
Endomyocardial fibrosis (EMF) continues to be an important and disabling disease in many parts of Africa, although its prevalence has declined in some parts of the continent. Increased access to medical care in general and increased availability of echocardiography in some parts of the continent have led...

Lack of evidence of myocardial damage in children with Plasmodium falciparum severe and complicated malaria from an endemic area for endomyocardial fibrosis

J. trop. pedriatr; 57 (4), 2011
Malaria is among the factors thought to be involved in the pathogenesis of endomyocardial fibrosis (EMF), a restrictive cardiomyopathy of unclear etiology, with no specific therapy, which affects predominantly children and adolescents. In Africa, regions endemic with EMF are also areas with high prevalen...

A population study of endomyocardial fibrosis in a rural area of Mozambique

N. Engl. j. med; 359 (1), 2008
Background: Endomyocardial fibrosis is the most common restrictive cardiomyopathy worldwide. It has no specific treatment and carries a poor prognosis, since most patients present with advanced heart failure. On the basis of clinical series, regional variations in distribution have been reported within s...